Preliminary experience with bevacizumab in combination with standard chemotherapeutic regimens in the treatment of non-small cell lung cancer: a retrospective study

Christos Emmanouilides; Dimitrios Philippou; Evdoxia Sapountzi; Eleni Diamandidou

首页> 外文期刊>Hematology/Oncology and Stem Cell Therapy >Preliminary experience with bevacizumab in combination with standard chemotherapeutic regimens in the treatment of non-small cell lung cancer: a retrospective study

【24h】

Preliminary experience with bevacizumab in combination with standard chemotherapeutic regimens in the treatment of non-small cell lung cancer: a retrospective study

机译：贝伐单抗联合标准化疗方案治疗非小细胞肺癌的初步经验：回顾性研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hematology/Oncology and Stem Cell Therapy》 |2008年第3期|共6页
作者
Christos Emmanouilides; Dimitrios Philippou; Evdoxia Sapountzi; Eleni Diamandidou;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类一般性问题;
关键词

相似文献

外文文献
中文文献
专利

1. First-Line Treatment with Bevacizumab and Platinum Doublet Combination in Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study in US Oncology Community Practices [J] . Orsolya E. Lunacsek, Arliene Ravelo, Anna D. Coutinho, Drugs - Real World Outcomes . 2016,第3期

机译：用非鳞状非小细胞肺癌贝伐单抗和白铂双铂的第一线治疗：美国肿瘤社区实践中的回顾性队列研究
2. Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC): Results From a Phase 2, Placebo-Controlled Study (GO27821) [J] . Wakelee H. A., Zvirbule Z., De Braud F., International Journal of Radiation Oncology, Biology, Physics . 2014,第5Suppla期

机译：奥那珠单抗联合一线贝伐单抗或培美曲塞为基础的化疗方案在晚期非鳞状非小细胞肺癌（nsNSCLC）中的疗效和安全性：来自2期安慰剂对照研究（GO27821）的结果
3. Comparison of carboplatin and paclitaxel with or without bevacizumab in chemotherapeutic regimens for unresectable stage III non-small cell lung cancer [J] . T. Ding, Z.-T. Li, X. Zhang, European review for medical and pharmacological sciences. . 2017,第16期

机译：卡铂和紫杉醇联合或不联合贝伐单抗治疗不可切除的Ⅲ期非小细胞肺癌的化疗方案比较
4. SAHA Treatment Reveals the Link between Histone Lysine Acetylation and Proteome in Non-small Cell Lung Cancer A549 Cells [C] . Quan Wu, Weiqing Xu, Lejie Cao, ASMS Conference on Mass Spectrometry and Allied Topics . 2014

机译：Saha治疗揭示了非小细胞肺癌A549细胞中组蛋白赖氨酸乙酰化和蛋白质组之间的联系
5. A Study of Erlotinib Monotherapy and in Combination with Pembrolizumab in Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer [D] . Liu, Qiong. 2021

机译：Erlotinib单疗法和蛋白质在先前未处理阶段I-IIIA非小细胞肺癌中的研究
6. First-Line Treatment with Bevacizumab and Platinum Doublet Combination in Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study in US Oncology Community Practices [O] . Orsolya E. Lunacsek, Arliene Ravelo, Anna D. Coutinho, 2016

机译：贝伐单抗和铂类双重药物联合治疗非鳞状非小细胞肺癌的一线治疗：美国肿瘤学社区实践的回顾性队列研究
7. Preliminary experience with bevacizumab in combination with standard chemotherapeutic regimens in the treatment of non-small cell lung cancer: a retrospective study [O] . Emmanouilides Christos, Philippou Dimitrios, Sapountzi Evdoxia, 2008

机译：贝伐单抗联合标准化疗方案治疗非小细胞肺癌的初步经验：回顾性研究

Preliminary experience with bevacizumab in combination with standard chemotherapeutic regimens in the treatment of non-small cell lung cancer: a retrospective study

著录项

相似文献

相关主题

期刊订阅